ARTICLE | Clinical News
Thrombus imaging agent containing a genetically engineered polypeptide
May 6, 1996 7:00 AM UTC
Bio-Technology General Corp. (BTGC), Iselin, N.J. Product: Thrombus imaging agent containing a genetically engineered polypeptide Use: Image and detect blood clots Status: BTGC licensee Merck Frosst ...